Mexico HIV AIDS Industry Outlook 2022 - 2026

See how Mexico HIV AIDS performed compared to key markets such as Swaziland, Cape Verde and Latvia.

Key Market Indicators

The HIV/AIDS treatment coverage rate in Mexico is expected to reach 67% of persons living with HIV by 2026, up from 57% in 2021. This is a yearly growth rate of 2.6%. Since 2005, the Mexican market has grown by 5.3 points on average each year. Mexico was ranked 89th in 2021, with El Salvador surpassing them with 57%. Cape Verde, Latvia and Zimbabwe respectively were numbers 2, 3 and 4. The HIV/AIDS prevalence rate among those aged 0-14 in Mexico is expected to reach 2,340 persons by 2026, a 0.2% increase from 2021's 2,310 persons. Since 1995, Mexico's demand has grown by 0.1% yearly. In 2021, Thailand overtook the country by reaching 2,310 persons. Nigeria, Mozambique and Tanzania followed suit at numbers 2, 3 and 4.

Mexico HIV AIDS Market Data and Forecasts

How much will Mexico HIV AIDS Market grow to 2026?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Mexico

Other Top Countries about HIV AIDS